A program for managing weight gain associated with atypical antipsychotics

Psychiatr Serv. 2003 Aug;54(8):1155-7. doi: 10.1176/appi.ps.54.8.1155.

Abstract

This study assessed the efficacy of a weight control program for patients taking atypical antipsychotics. Thirty-one patients with schizophrenia or schizoaffective disorder participated in a 12-week weight control program that incorporated nutrition, exercise, and behavioral interventions. Changes in patients' weight and in body mass index (BMI) were recorded and compared with those of 15 patients in a control group. The intervention group had a mean weight loss of 2.7 kg (six pounds) and a mean reduction of.98 BMI points, compared with a mean weight gain of 2.9 kg (6.4 pounds) and a mean gain of 1.2 BMI points in the control group. These data suggest that the intervention was effective in this group of patients. Professionals treating persons who are taking atypical antipsychotics should encourage them to engage in weight control activities.

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Behavior Therapy
  • Body Mass Index
  • Day Care, Medical
  • Exercise
  • Female
  • Humans
  • Male
  • Middle Aged
  • Obesity / chemically induced
  • Obesity / therapy*
  • Psychotherapy, Group
  • Psychotic Disorders / drug therapy*
  • Risk Factors
  • Schizophrenia / drug therapy*
  • Treatment Outcome
  • United States
  • Weight Gain / drug effects*
  • Weight Loss

Substances

  • Antipsychotic Agents